[PHAS] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[PHAS] PhaseBio Pharmaceuticals, Inc.
Announcement Date
15-Mar-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- -20.81%
YoY- -168.07%
Quarter Report
PHAS's Result
PHAS's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 335 10,338 0 0 241 703 320 3.09%
PBT -31,924 -27,079 -27,358 -30,375 -25,143 -28,142 -14,905 66.08%
Tax -3,126 1,600 -1,426 -4,071 -4,289 -3,665 -239 454.26%
NP -31,924 -28,679 -27,358 -30,375 -25,143 -28,142 -14,905 66.08%
Tax Rate - - - - - - - -
Total Cost 32,259 39,017 27,358 30,375 25,384 28,845 15,225 64.89%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin -9,529.55 -277.41 0.00 -9,492,187,500,000,000.00 -10,432.78 -4,003.13 -4,657.81 61.09%
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS -0.66 -0.60 -0.87 -1.03 -0.86 -0.98 -0.52 17.20%
EPS Diluted -0.66 -0.60 -0.87 -1.03 -0.86 -0.98 -0.52 17.20%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.